Market Overview

5 Largest Price Target Changes For Tuesday

Share:

 

  • Goldman Sachs lowered WABCO Holdings Inc. (NYSE: WBC) price target from $135 to $105. WABCO shares declined 0.97 percent to $89.00 in pre-market trading.
  • Morgan Stanley raised the price target for GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) from $149 to $152. GW Pharmaceuticals shares rose 2.94 percent to $91.09 in pre-market trading.
  • Goldman Sachs lowered the price target on Mobileye NV (NYSE: MBLY) from $45 to $40. Mobileye shares dropped 1.36 percent to $39.25 in pre-market trading.
  • BMO Capital lowered the price target on Regulus Therapeutics Inc (NASDAQ: RGLS) from $16 to $4. Regulus Therapeutics shares fell 48.10 percent to $2.60 in pre-market trading.
  • Goldman Sachs raised the price target for Taiwan Semiconductor Mfg. Co. Ltd. (ADR) (NYSE: TSM) from NT$173 to NT$180. Taiwan Semiconductor shares rose 1.20 percent to $25.20 in pre-market trading.

Latest Ratings for GWPH

DateFirmActionFromTo
Aug 2020Raymond JamesInitiates Coverage OnMarket Perform
Aug 2020HC Wainwright & Co.MaintainsBuy
Aug 2020NeedhamMaintainsBuy

View More Analyst Ratings for GWPH
View the Latest Analyst Ratings

 

Related Articles (WBC + GWPH)

View Comments and Join the Discussion!

Posted-In: Price Target ChangesPrice Target Analyst Ratings

Latest Ratings

StockFirmActionPT
MRTXHC Wainwright & Co.Maintains257.0
NVDATruist SecuritiesMaintains672.0
NVDASusquehannaMaintains625.0
BLKBMO CapitalMaintains715.0
BLKDeutsche BankMaintains838.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com